Banner

News

Article

AI application aims to streamline cancer care by integrating patient data

Author(s):

Key Takeaways

  • CareIntellect for Oncology uses AI to consolidate patient data, enhancing decision-making efficiency for clinicians.
  • The platform initially targets prostate and breast cancer, aiding in disease tracking and clinical trial identification.
SHOW MORE

Cloud-based tool makes data review more efficient.

AI tool to help oncologists: ©Phonlamaiphoto -stock.adobe.com

AI tool to help oncologists: ©Phonlamaiphoto -stock.adobe.com

GE HealthCare introduced "CareIntellect for Oncology," a cloud-based tool designed to simplify the management of cancer patients' data for care teams. The platform, expected to launch in the U.S. in 2025, aims to reduce the time clinicians spend on reviewing multi-modal data and streamline access to critical information for more efficient decision-making.

What is it?

This tool uses generative AI to organize and summarize complex patient information, such as medical images, clinical notes, and device readings, all into one easily navigable interface. Initially focusing on prostate and breast cancer, CareIntellect for Oncology helps care teams track disease progression, flag deviations from treatment plans, and identify suitable clinical trials. According to GE HealthCare, the platform aims to cut down the hours typically required to review patient history to just minutes by consolidating data from various sources.

What it means for doctors

Clinicians frequently face challenges when treating cancer patients due to the overwhelming volume of information scattered across different systems. For oncologists, balancing clinical trial research with individualized patient care has become increasingly difficult. In fact, 80% of oncologists report struggling to keep up with the growing amount of research and trial information.

CareIntellect aims to ease this burden by providing a centralized overview of each patient’s treatment journey. Its AI-driven features will help clinicians identify missed labs or treatments, assess responses to therapies, and even determine trial eligibility. For example, the system can alert doctors when a patient’s scheduled test has been missed, potentially delaying treatment.

Tampa General Hospital and UT Southwestern Medical Center are set to be among the first to evaluate the platform, with the application rolling out more widely in 2025. GE HealthCare also plans to expand its availability to Canada, the UK, and Ireland in the future.

The launch of CareIntellect is part of GE HealthCare's broader strategy to help hospitals integrate clinical and operational applications more easily. By leveraging a common cloud-first infrastructure, the company hopes to reduce the time and cost associated with digital transformations, allowing healthcare providers to spend more time on patient care rather than IT setup.

For oncologists, CareIntellect for Oncology offers a potential solution to the increasingly complex challenge of managing patient data while delivering personalized care.

Related Videos